These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction. Matsubara J; Sugiyama S; Nozaki T; Sugamura K; Konishi M; Ohba K; Matsuzawa Y; Akiyama E; Yamamoto E; Sakamoto K; Nagayoshi Y; Kaikita K; Sumida H; Kim-Mitsuyama S; Ogawa H J Am Coll Cardiol; 2011 Feb; 57(7):861-9. PubMed ID: 21310324 [TBL] [Abstract][Full Text] [Related]
3. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach. Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627 [TBL] [Abstract][Full Text] [Related]
5. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction. Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232 [TBL] [Abstract][Full Text] [Related]
6. Opportunistic screening models for high-risk men and women to detect diastolic dysfunction and heart failure with preserved ejection fraction in the community. Gohar A; Kievit RF; Valstar GB; Hoes AW; Van Riet EE; van Mourik Y; Bertens LC; Boonman-Winter LJ; Bots ML; Den Ruijter HM; Rutten FH Eur J Prev Cardiol; 2019 Apr; 26(6):613-623. PubMed ID: 30482050 [TBL] [Abstract][Full Text] [Related]
13. The relationship between serum fibrosis markers and restrictive ventricular filling in patients with heart failure with reduced ejection fraction: A technetium-99m radionuclide ventriculography study. Lin YT; Lin YH; Wu XM; Ko CL; Yen RF; Chen YH; Hsu RB; Lee CM; Wang SS; Chen MF; Wu YW Oncotarget; 2017 Jan; 8(2):2381-2390. PubMed ID: 27924061 [TBL] [Abstract][Full Text] [Related]
14. The usefulness of C-reactive protein for the prediction of post-infarct left ventricular systolic dysfunction and heart failure. Swiatkiewicz I; Taub PR Kardiol Pol; 2018; 76(5):821-829. PubMed ID: 29633232 [TBL] [Abstract][Full Text] [Related]
16. High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death. Pellicori P; Zhang J; Cuthbert J; Urbinati A; Shah P; Kazmi S; Clark AL; Cleland JGF Cardiovasc Res; 2020 Jan; 116(1):91-100. PubMed ID: 31350553 [TBL] [Abstract][Full Text] [Related]
17. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction. Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424 [TBL] [Abstract][Full Text] [Related]
18. NT-pro-BNP during isotonic and isometric exercise in heart failure patients with preserved LV ejection fraction. Zdrenghea DT; Ilea M; Bodizs G; Sitar-Tăut A; Zdrenghea M; Pop D Clin Lab; 2014; 60(12):2055-61. PubMed ID: 25651741 [TBL] [Abstract][Full Text] [Related]
19. Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database Initiative. Ferreira JP; Girerd N; Duarte K; Coiro S; McMurray JJ; Dargie HJ; Pitt B; Dickstein K; Testani JM; Zannad F; Rossignol P; Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28159825 [TBL] [Abstract][Full Text] [Related]
20. Modified Glasgow Prognostic Score is a novel predictor of clinical outcome in heart failure with preserved ejection fraction. Bolat I; Biteker M Scand Cardiovasc J; 2020 Jun; 54(3):174-178. PubMed ID: 31965867 [No Abstract] [Full Text] [Related] [Next] [New Search]